References
- Consensus Statement. EASL International Consensus Conference on Hepatitis C. J Hepatol 1999;30:956–61.
- Di Bisceglie AM. Hepatitis C. Lancet 1998;351: 351–5.
- McHutchinson JG, Gordon S, Schiff ER, Schiffman ML, Lee WM, Rustgi VK, et al. Interferon alpha-2b monotherapy versus interferon alpha-2b plus ribavirin as initial treatment for chronic hepatitis C: results of a US multicenter randomized controlled trial. N Engl J Med 1998;339:1485–92.
- Davis GL, Esteban-Mur R, Rustgi VK, Hoefs J, Gordon S, Trepo C, et al. Recombinant interferon alpha-2b alone or in combination with ribavirin retreatment of interferon relapse in chronic hepatitis C. N Engl J Med 1998;339:1493–9.
- Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomized trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C. Lancet 1998;352:1426–32.
- Soardo G, Pirisi M, Fonda M, Fabris C, Falleti E, Toniutto T, et al. Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C. J Interferon Cytokine Res 1995;15:705–12.
- Kuzushita N, Hayashi N, Katayama K, Kanto T, Oshita M, Hagiwara H, et al. High levels of serum interleukin-10 are associated with a poor response to interferon treatment in patients with chronic hepatitis C. Scand J Gastroenterol 1997;32:167–74.
- Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431–5.
- Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Tute A, et al. Detection of hepatitis C viral sequences in blood donation by ‘nested’ polymerase chain reaction and prediction of infectivity. Lancet 1990;1:1419–22.
- Deppish R, Schmitt V, Bommer J, Hannsch M, Ritz E, Rautenberg EW. Fluid phase generation of terminal complement complex as a novel index of biocompatibilty. Kidney Int 1990; 37:696–706.
- Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 1999;30:595–601.
- Tsai S-L, Liaw Y-F, Chen M-H, Huang C-Y, Kuo GC. Detection of type 1-like T-helper cells in hepatitis C virus infection: implications for hepatitis C chronicity. Hepatology 1997;25: 449–58.
- Shapiro S, Gershtein V, Elias N, Zuckerman E, Salman N, Lahat N. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN alpha) treatment. Clin Exp Immunol 1998;111:55–60.